Researchers in California for the first time have reprogrammed human induced pluripotent stem (iPS) cells into germ cells that eventually become eggs and sperm, possibly opening the door for new treatments for infertility using patient-specific cells.
The iPS cells were coaxed into forming germ line precursor cells that include genetic material that may be passed on to a child.
“This finding could be important for people who are rendered infertile through disease or injury. We may, one day, be able to replace the germ cells that are lost,” said Amander Clark, a Broad Stem Cell Research Center scientist and senior author of the study. “And these germ cells would be specific and genetically related to that patient.”
Theoretically, an infertile patient’s skin cells, for example, could be taken and reprogrammed into iPS cells, which, like embryonic stem cells, have the ability to become every cell type in the human body.
Those cells could then be transformed into germ line precursor cells that would eventually become eggs and sperm.
Clark cautioned, however, that scientists are still many years from using these cells in patients to treat infertility.
There is still much to be learned about the process of making high quality germ cells in the lab.
In another important finding, Clark’s team discovered that the germ line cells generated from human iPS cells were not the same as the germ line cells derived from human embryonic stem cells.
Certain vital regulatory processes were not performed correctly in the human iPS derived germ cells, said Clark, an assistant professor of molecular, cell and developmental biology.
So it’s crucial, Clark contends, that work continue on the more controversial human embryonic stem cells that come from donated, excess material from in vitro fertilization that would otherwise be destroyed.
When germ cells are formed, they need to undergo a specific series of biological processes, an essential one being the regulation of imprinted genes.
This is required for the germ cells to function correctly. If these processes are not performed the resulting eggs or sperm, are at high risk for not working as they should.
This has significant consequences, given that the desired outcome is a healthy child.
“Further research is needed to determine if germ line cells derived from iPS cells, particularly those which have not been created by retroviral integration, have the ability to correctly regulate themselves like the cells derived from human embryonic stem cells do,” Clark said. “When we looked at the germ cells derived from embryonic stem cells, we found that they regulated as expected, whereas those from the iPS cells were not regulated in the same way. We need to do much more work on this to find out why.”
Clark and her team plan to examine more iPS cell lines and evaluate the resulting germ cells derived from them to determine if the incorrect regulation remains a problem.
Creating germ cells from embryonic stem cells is challenging and the resulting proportions are low - about 10 percent of embryonic stem cells go on to become germ cells.
Clark said creating germ cells from iPS cells proved just as challenging. Putting the iPS cells in an environment where germ cells thrive naturally, among fetal gonadal cells, proved to be the key.
About 4.5 million American women are infertile. Current treatments include donor eggs and sperm and surrogacy.
If germ cells can be derived from a patients own adult cells using reprogramming followed by germ cell differentiation, this adds an important strategy into the tool box of options currently available to treat infertility, Clark said.
A man with a low sperm count, for example, may be able to have more of his own sperm generated to fertilize his partner’s egg.
The study took about 2.5 years, first focusing on growing germ cells from human embryonic stem cells and then from iPS cells.
It took just seven days to get germ line precursor cells from the iPS cells, once Clark and her team landed on the appropriate culture environment.
The study appears in the early online edition of the peer-reviewed journal Stem Cells.
Contact: t http://www.stemcell.ucla.edu
Contact: Amander Clark, clarka@ucla.edu
...
For many years we have provided stem cell-related news and
analysis free of charge on this Web Site, supported by
advertising and subscription income. Unfortunately, in today’s
economy, advertising placements are at an all-time low. That has
forced us (and other publishers) to seek income elsewhere.
Hence, the subscription fees for premium content.
1) You read about stem cell research you'll never hear about
in the general press, and you'll get the complete article, not just a snippet.
2) Important references are clickable links. (e.g., a
reference to a research institution
or researcher's lab site or more
information about a disease or disorder
are highlighted and clickable as Web links.)
3) Full citations are provided for all journal articles
so you can access the original research.
4) Links to article abstracts are provided.
5) Links to researcher e-mail addresses and lab Web sites
are provided whenever available.
6) Graphic images are provided when available.
7) Links to Related Articles in our database of more than
2,000 stem cell research articles.
